Interestingly, Claudin-low breast tumors expressing high levels of RSK3 displayed increased TGFβ signaling (Fig. 5E), decreased cellular senescence (Fig. 5F) and decreased NF-κB (Fig. 5G) molecular signatures. This evidence concerns the gene NFKB1 and breast neoplasm.